The largest database of trusted experimental protocols

Mda ma 231

Manufactured by STEMCELL
Sourced in Canada

The MDA-MB-231 cell line is a triple-negative breast cancer cell line derived from a metastatic site. This cell line is commonly used in cancer research to study the biology and behavior of triple-negative breast cancer.

Automatically generated - may contain errors

2 protocols using mda ma 231

1

Mammosphere Formation in Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF-7 and MDA-MB-231 human breast cancer cells were purchased from the Korea Cell Line Bank (KCLB, Seoul, Korea) and incubated in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (Gibco, CA, USA) in an incubator (37 °C, 5% CO2). Human breast cancer cells were cultured at 0.5 × 104 (MDA-MA-231) and 4 × 104 (MCF-7) cells per plate in an ultralow attachment 6-well plate with a MammoCultTM culture medium (StemCell Technologies, Vancouver, BC, Canada) supplemented with hydrocortisone and heparin for 1 week in an incubator (37 °C, 5% CO2). Mammosphere formation was assessed using the National Institute of Standards and Technology (NIST)’s integrated colony enumerator (NICE) program [63 (link)]. Mammosphere formation was determined by examining the mammosphere formation efficiency (MFE) (%) [64 (link)].
+ Open protocol
+ Expand
2

Mammosphere Formation of Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MA-231 and MCF-7 were purchased from the Korea Cell Line Bank (Seoul, Korea) and cultured in Dulbecco’s Modified Eagle’s Medium containing 10% fetal bovine serum (Corning, Glendalec, AZ, USA) and 1% penicillin/streptomycin solution (Corning) in an incubator with a 5% CO2 atmosphere. MDA-MA-231 (1 × 104 per well) and MCF-7 (4 × 104 per well) were incubated in a 24- or 6-well ultralow attachment plate with MammoCultTM culture medium (StemCell Technologies, Vancouver, BC, Canada) containing hydrocortisone (0.5 μg/mL) and heparin (4 μg/mL) for 7 days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!